As
filed with the Securities and Exchange Commission on May 1,
2009
|
Registration
No. 333-154910
|
Delaware
|
52-2286452
|
(State or Other
Juris-
|
(I.R.S.
Employer
|
diction
of Incorporation
|
Identification
Number)
|
or
Organization)
|
Large
accelerated filer
|
o
|
Accelerated
filer
|
o
|
|
Non-accelerated
filer
|
o
|
Smaller
Reporting Company
|
x
|
ARNO THERAPEUTICS, INC. | |||
|
By:
|
/s/ Brian Lenz | |
Brian
Lenz
Chief
Financial Officer
|
|||
Signature
|
Title
|
Date
|
||
*
|
Chief
Executive Officer and Director (principal executive
officer)
|
May
1, 2009
|
||
Roger
G. Berlin, M.D.
|
||||
/s/ Brian Lenz
|
Chief
Financial Officer
|
May
1, 2009
|
||
Brian
Lenz
|
(principal
financial and accounting officer)
|
|||
*
|
Non-Executive
Chairman and Director
|
May
1, 2009
|
||
Arie
S. Belldegrun, M.D.
|
||||
*
|
Director
|
May
1, 2009
|
||
Robert
I. Falk
|
||||
|
||||
*
|
Director
|
May
1, 2009
|
||
William
F. Hamilton, Ph.D.
|
||||
|
||||
Director | ||||
Peter
M. Kash
|
|
May
__, 2009
|
||
*
|
Director
|
May
1, 2009
|
||
Joshua
A. Kazam
|
||||
*
|
Director
and Secretary
|
May
1, 2009
|
||
David
M. Tanen
|
||||
* /s/ Brian Lenz | ||||
Brian
Lenz
|
||||
Attorney-in-fact
|